Results 241 to 250 of about 463,262 (274)
Some of the next articles are maybe not open access.

An additional recommendation on reporting depression

American Journal of Psychiatry, 1984
J A, Hamilton, R M, Hirschfeld
openaire   +2 more sources

Reboxetine: additional benefits to the depressed patient.

Journal of psychopharmacology (Oxford, England), 1998
Reboxetine is a new selective noradrenaline reuptake inhibitor that has been shown to be effective in both the short-(4-8 weeks) and long-term (up to 12 months) treatment of depression. Four positive placebo-controlled studies showed reboxetine to have significant antidepressant efficacy; the response rate (> or = 50% decrease in HAM-D total score ...
openaire   +1 more source

Lithium Addition in Treatment-Resistant Depression

The Canadian Journal of Psychiatry, 1986
C, de Montigng   +2 more
openaire   +2 more sources

Depression and Insulin Resistance: Additional Support for the Novel Heuristic Model in Perimenopausal Depression

American Journal of Psychiatry, 2015
Jokelainen Jari   +10 more
openaire   +3 more sources

Addition of Olanzapine for Treatment-Resistant Depression

American Journal of Psychiatry, 2001
WILLIAM PITCHOT, MARC ANSSEAU
openaire   +1 more source

Respiratory Depression with Addition of Fentanyl to Spinal Anesthesia

Anesthesia & Analgesia, 1997
Spencer S. Liu   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy